Search research articles
Contact Us
Filters
Showing results (31-40 of 72) with videos related to
Page
of 8
Sort By:
Expert Opinion on Drug Metabolism & Toxicology
|
June 27, 2025
Evaluation of the role of comedication properties in the severity of drug-induced liver injury using machine learning techniques
Irene Victoria Bermúdez-Pérez, Ismael Alvarez-Alvarez, Inmaculada Medina-Cáliz, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
September 9, 2018
The influence of drug properties and host factors on delayed onset of symptoms in drug-induced liver injury
Andres Gonzalez-Jimenez, Kristin McEuen, Minjun Chen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
August 8, 2017
High Prevalence of Ibuprofen Drug-Induced Liver Injury in Spanish and Latin-American Registries
Miguel E Zoubek, Andres González-Jimenez, Inmaculada Medina-Cáliz, et al.
British Journal of Pharmacology
|
June 25, 2025
Intestinal permeability and immune-inflammatory markers in patients with idiosyncratic drug-induced liver injury, drug-induced steatosis and metabolic dysfunction-associated steatotic liver disease (MASLD)
Daniel E Di Zeo-Sánchez, Irene Díaz-Alberola, José María Pinazo-Bandera, et al.
International Journal of Molecular Sciences
|
July 13, 2024
Idiosyncratic Drug-Induced Liver Injury and Amoxicillin-Clavulanate: Spotlight on Gut Microbiota, Fecal Metabolome and Bile Acid Profile in Patients
Sara Román-Sagüillo, Raisa Quiñones Castro, María Juárez-Fernández, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
May 25, 2013
Role of chemical structures and the 1331T>C bile salt export pump polymorphism in idiosyncratic drug-induced liver injury
Eugenia Ulzurrun, Camilla Stephens, Esperanza Crespo, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
October 27, 2020
Incidence and prevalence of acute hepatitis E virus infection in patients with suspected Drug-Induced Liver Injury in the Spanish DILI Registry
Judith Sanabria-Cabrera, Rocío Sanjuán-Jiménez, Encarnación Clavijo, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
July 28, 2022
A new framework for advancing in drug-induced liver injury research. The Prospective European DILI Registry
Einar S Björnsson, Camilla Stephens, Edmond Atallah, et al.
Clinical Pharmacology and Therapeutics
|
September 20, 2021
Lymphocyte Profile and Immune Checkpoint Expression in Drug-Induced Liver Injury: An Immunophenotyping Study
Alejandro Cueto-Sanchez, Hao Niu, Enrique Del Campo-Herrera, et al.
Pharmacological Research
|
July 11, 2022
Microbiota diversity in nonalcoholic fatty liver disease and in drug-induced liver injury
Cristina Rodriguez-Diaz, Bernard Taminiau, Alberto García-García, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 72) with videos related to
Sort By:
Page
of 8
Expert Opinion on Drug Metabolism & Toxicology
|
June 27, 2025
Evaluation of the role of comedication properties in the severity of drug-induced liver injury using machine learning techniques
Irene Victoria Bermúdez-Pérez, Ismael Alvarez-Alvarez, Inmaculada Medina-Cáliz, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
September 9, 2018
The influence of drug properties and host factors on delayed onset of symptoms in drug-induced liver injury
Andres Gonzalez-Jimenez, Kristin McEuen, Minjun Chen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
August 8, 2017
High Prevalence of Ibuprofen Drug-Induced Liver Injury in Spanish and Latin-American Registries
Miguel E Zoubek, Andres González-Jimenez, Inmaculada Medina-Cáliz, et al.
British Journal of Pharmacology
|
June 25, 2025
Intestinal permeability and immune-inflammatory markers in patients with idiosyncratic drug-induced liver injury, drug-induced steatosis and metabolic dysfunction-associated steatotic liver disease (MASLD)
Daniel E Di Zeo-Sánchez, Irene Díaz-Alberola, José María Pinazo-Bandera, et al.
International Journal of Molecular Sciences
|
July 13, 2024
Idiosyncratic Drug-Induced Liver Injury and Amoxicillin-Clavulanate: Spotlight on Gut Microbiota, Fecal Metabolome and Bile Acid Profile in Patients
Sara Román-Sagüillo, Raisa Quiñones Castro, María Juárez-Fernández, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
May 25, 2013
Role of chemical structures and the 1331T>C bile salt export pump polymorphism in idiosyncratic drug-induced liver injury
Eugenia Ulzurrun, Camilla Stephens, Esperanza Crespo, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
October 27, 2020
Incidence and prevalence of acute hepatitis E virus infection in patients with suspected Drug-Induced Liver Injury in the Spanish DILI Registry
Judith Sanabria-Cabrera, Rocío Sanjuán-Jiménez, Encarnación Clavijo, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
July 28, 2022
A new framework for advancing in drug-induced liver injury research. The Prospective European DILI Registry
Einar S Björnsson, Camilla Stephens, Edmond Atallah, et al.
Clinical Pharmacology and Therapeutics
|
September 20, 2021
Lymphocyte Profile and Immune Checkpoint Expression in Drug-Induced Liver Injury: An Immunophenotyping Study
Alejandro Cueto-Sanchez, Hao Niu, Enrique Del Campo-Herrera, et al.
Pharmacological Research
|
July 11, 2022
Microbiota diversity in nonalcoholic fatty liver disease and in drug-induced liver injury
Cristina Rodriguez-Diaz, Bernard Taminiau, Alberto García-García, et al.
Page
of 8